Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,689.90
-0.60 (-0.04%)
Oct 23, 2025, 3:30 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.05 trillion as of October 23, 2025. Its market cap has decreased by -11.56% in one year.
Market Cap
4.05T
Enterprise Value
3.82T
Revenue
537.77B
Ranking
n/a
PE Ratio
39.07
Stock Price
1,689.90
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.05T, an increase of 14,585.02%. That is a compound annual growth rate of 22.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2025 | 4.06T | -10.38% |
Dec 31, 2024 | 4.53T | 49.78% |
Dec 29, 2023 | 3.02T | 25.77% |
Dec 30, 2022 | 2.40T | 18.41% |
Dec 31, 2021 | 2.03T | 42.77% |
Dec 31, 2020 | 1.42T | 36.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Divi's Laboratories | 1.75T |
Cipla | 1.34T |
Apollo Hospitals Enterprise | 1.15T |
Mankind Pharma | 1.01T |
Zydus Lifesciences | 1.01T |
Fortis Healthcare | 828.87B |
Alkem Laboratories | 663.29B |
Aurobindo Pharma | 639.17B |